BIOMARKER:

Rbsig overexpression

Rbsig overexpression Rbsig overexpression	HER2 Positive Breast Cancer HER2 Positive Breast Cancer	Rbsig overexpression Rbsig overexpression	HER2 Positive Breast Cancer HER2 Positive Breast Cancer	lapatinib Sensitive: C3 – Early Trials	lapatinib Sensitive: C3 – Early Trials
Rbsig overexpression Rbsig overexpression	HER2 Positive Breast Cancer HER2 Positive Breast Cancer	Rbsig overexpression Rbsig overexpression	HER2 Positive Breast Cancer HER2 Positive Breast Cancer	trastuzumab + lapatinib Sensitive: C3 – Early Trials	trastuzumab + lapatinib Sensitive: C3 – Early Trials
Rbsig overexpression Rbsig overexpression	HER2 Positive Breast Cancer HER2 Positive Breast Cancer	Rbsig overexpression Rbsig overexpression	HER2 Positive Breast Cancer HER2 Positive Breast Cancer	trastuzumab Sensitive: C3 – Early Trials	trastuzumab Sensitive: C3 – Early Trials

Associations